ADARx Pharma

News

The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.

News

Roche has added to its weight-loss drug pipeline again, turning to China's Rona Therapeutics for an RNAi candidate targeting ALK7.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.